ClinicalTrials.Veeva

Menu
U

University of Wisconsin | Department of Ophthalmology and Visual Sciences - Clinical Eye Research Unit

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

DKN-01
Nivolumab
Tiotropium bromide
Sacituzumab
Taxane
BMN 673
Pertuzumab
Salmeterol xinafoate
Paclitaxel
Nicotine

Parent organization

This site is a part of University of Wisconsin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 63 total trials

A Study to Evaluate Higher Dose (HD) Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy Previously Treated With Risdiplam (ASCEND)

The primary objective of this study is to evaluate motor function following treatment with HD nusinersen in participants with spinal muscular atrophy...

Enrolling
Spinal Muscular Atrophy
Drug: Nusinersen

To determine the safety and effectiveness of IMPEDE-FX RapidFill to increase the percentage of subjects with shrinkage of the abdominal aortic aneury...

Enrolling
Aortic Aneurysm, Abdominal
Procedure: EndoVascular Aneurysm Repair
Device: IMPEDE-FX RapidFill Implants

This study will assess differences in patient preferences and glucose control between continuous glucose monitoring and standard glucose checks in pr...

Active, not recruiting
Type2Diabetes
Pregnancy in Diabetic
Device: Dexcom G6 CGM
Other: Participant Finger Stick Glucose Monitoring

In this first-in human, phase I/IIa study, the safety and efficacy of \[212Pb\]VMT01, an alpha-particle emitting therapeutic agent targeted to melano...

Enrolling
Mucosal Melanoma
Melanoma Stage IV
Drug: [203Pb]VMT01
Drug: [212Pb]VMT01
Recently updated

This research study is studying a combination of hormonal therapy, chemotherapy, and immunotherapy as a possible treatment for metastatic hormone-sen...

Active, not recruiting
Metastasis Prostate Adenocarcinoma
Prostate Adenocarcinoma
Drug: Docetaxel
Drug: Nivolumab

The purpose of the study is to assess procedural completion, the post-operative stone clearance and the safety profile following robotic mini-Percuta...

Enrolling
Kidney Calculi
Device: Robotic-assisted mini-PCNL

DF1001-001 is a study of a new molecule that targets natural killer (NK) cells and T-cell activation signals to specific receptors on cancer cells. T...

Enrolling
Solid Tumor, Adult
Drug: Nab paclitaxel
Drug: Nivolumab

Trial sponsors

University of Wisconsin (UW) logo
L
J
A
A
A
Biogen logo
Debiopharm logo
D
Duke University logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems